30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

First U.S. Case with DT MedTech's H3 Total Ankle -

DT MedTech's Hintermann Series H3™ Total Ankle was successfully implanted in its first U.S. procedure. Full product launch will commence in late 2019. The three-component, non-cemented, non-constrained system has been marketed ex-U.S. for 18 years. In 2Q19, the device received FDA premarket approval. H3 complements the company's H2® two-piece total ankle, also available in the U.S. One instrument set can be used to implant both devices, as well as with H2 when used in revision procedures. (DT MedTech, LLC, 9/25/19)